{"schema_version":"secwatch.filing_event.v1","accession":"0000078003-24-000130","form_type":"8-K","ticker":"PFE","cik":"0000078003","company_name":"PFIZER INC","filed_at":"2024-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.866939+00:00","generated_at":"2026-05-31T22:21:33.028319+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pfizer begins external search for successor to Chief Scientific Officer Mikael Dolsten","bullets":["CSO and President of R&D Mikael Dolsten to step down after over 15 years; external search launched.","Dr. Dolsten will stay in current role until successor is appointed, at least through Feb 28, 2025.","No successor named; transition process formally announced on July 9, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0000078003-24-000130","json":"https://secwatch.observer/filing/0000078003-24-000130.json","markdown":"https://secwatch.observer/filing/0000078003-24-000130.md","text":"https://secwatch.observer/filing/0000078003-24-000130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/78003/000007800324000130/0000078003-24-000130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/78003/000007800324000130/pfe-20240709.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T22:21:33.028319+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b4ac2552aa","claim":"Mikael Dolsten departed as Chief Scientific Officer and President, Pfizer Research & Development at PFIZER INC.","evidence_excerpt":"On July 9, 2024, Pfizer Inc. (the \"Company\") announced that it is beginning the process of finding a successor for Dr. Mikael Dolsten, the Company’s Chief Scientific Officer and President, Pfizer Research & Development after his more than 15-year distinguished career with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/78003/000007800324000130/0000078003-24-000130-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Role","value":"Chief Scientific Officer and President, Pfizer Research & Development"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}